Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

CANADA: Drug-Resistant Gonorrhea Prompts New Treatment Guidelines in Ont.


Toronto Sun (04.30.2013) Aids Weekly Plus

Ontario health officials are recommending a new treatment combination of the injectable drug ceftriaxone and the antibiotic pill azithromycin for gonorrhea, following the lead of the US Centers for Disease Control and Prevention. The recommendation comes in response to the spread of some 32 strains of gonorrhea that are resistant to standard antibiotics. Gonorrhea is the second most common sexually transmitted infection in North America.


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in May 1, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.